Nutex Health, Inc. (NUTX)
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-302014-Mar-312013-Dec-31
Fiscal PeriodQ3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014Q1-FY2014Q4-FY2013
Operating Cash Flow99,514,000$27,257,000$50,965,000$54,807$6,788,000$13,260,000$3,051,000$(1,776,218$)1,968,338$12,319$1,052,013$4,505,994$(7,301,945$)17,661,637$35,741,422$(567,063$)88,229,752$(189,766$)(495,237$)(872,992$)(1,490,225$)(861,756$)(823,783$)(864,814$)232,718$(220,735$)(218,828$)(273,204$)(191,078$)(155,853$)(242,977$)(124,715$)(73,652$)23,131$58,733$(282,435$)192,899$(28,122$)(14$)(119,856$)(205,545$)(254,210$)616,082$2,875$(189,748$)
Investing Cash Flow(302,000$)196,000$(64,000$)(3,336,018$)(267,000$)(1,270,000$)(733,000$)865,599$(3,619,422$)(3,069,919$)(5,416,140$)7,880,050$(5,890,738$)2,265,113$(8,591,823$)3,888,267$(61,236,305$)50,193$0$(2,656$)(662,080$)(24,814$)(19,559$)(41,743$)(116,964$)0$0$0$33,073$(225$)(42,018$)11,220$(25,892$)22,103$(21,147$)14,946$6,854$0$0$(5,026$)(1$)0$0$(4,738$)0$
Purchases of Property and Equipment302,000$751,000$64,000$617,000$559,000$733,000$3,069,919$4,376,983$8,029,903$8,591,823$61,188,768$0$0$0$(11,212$)10,994$42,477$41,743$75$3,229$0$0$(5,026$)0$0$0$(2,026$)
Financing Cash Flow(29,897,000$)(15,449,000$)(6,812,000$)(2,986,229$)(421,000$)(1,188,000$)5,686,000$(3,914,058$)(4,276,513$)2,975,395$2,945,398$(14,751,579$)2,212,861$(7,884,619$)(27,709,393$)393,323$(8,445,730$)103,693$391,120$(22,047$)3,090,060$186,557$231,152$2,227,172$(1,929$)173,000$209,500$324,000$151,965$168,043$214,992$176,500$94,730$(34,747$)(48,525$)160,986$(89,613$)5,900$2,256$30,180$0$(3,100$)(55,000$)3,600$0$
End Cash Position166,048,000$96,733,000$84,729,000$40,640,000$46,909,281$40,807,975$30,006,419$22,002,056$26,826,733$32,754,330$32,836,535$34,255,264$36,118,284$3,741,458$26,931$27,742$63,622$167,739$1,065,434$10,029$75,456$7,036$119,267$3,182$50,917$60,245$9,449$15,489$3,524$73,527$10,522$21,829$33,370$24,375$122,291$18,754$40,976$38,734$126,833$332,379$589,689$26,870$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow99,212,000$26,506,000$50,901,000$54,807$6,171,000$12,701,000$2,318,000$(1,776,218$)1,968,338$(3,057,600$)(3,324,970$)4,505,994$(7,301,945$)9,631,734$27,149,599$(567,063$)27,040,984$(189,766$)(495,237$)(872,992$)(1,479,013$)(872,750$)(866,260$)(906,557$)232,718$(220,735$)(218,828$)(273,204$)(191,078$)(155,853$)(242,977$)(124,715$)(73,652$)23,056$58,733$(282,435$)189,670$(28,122$)(14$)(114,830$)(205,545$)(254,210$)616,082$4,901$(189,748$)